Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Clinical trial NCT01898715 · COMPLETED
Trial details
- NCT number
- NCT01898715
- Sponsor
- Millendo Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-13
- Primary completion
- 2016-11-02
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.